Julie Kim
CEO-elect of Takeda with extensive leadership in biopharma, formerly president of Takeda's U.S. business unit and interim head of global portfolio; focuses on precision medicine, AI adoption, and patient-centric growth strategies.
Best podcasts with Julie Kim
Ranked by the Snipd community
14 snips
Apr 9, 2026 • 32min
Reimagining Biopharma: Precision Medicine, Patients, and Purpose with Takeda CEO-Elect
Julie Kim, CEO-elect of Takeda and longtime biopharma leader, talks precision medicine and AI-driven drug development. She explores how individualized therapies strain current trial and regulatory models. She outlines using AI, robotics, and real-world data to speed R&D and improve access. She also discusses sharpening Takeda’s growth story while keeping a patient-first culture.
